Answers are grounded in this paper and cite their sources.
Cohort study reveals reduced glaucoma and macular degeneration risks with diabetes drugs in adults, suggesting ocular protective benefits that require trial confirmation.
Results of this cohort study suggest that, although diabetes was clearly associated with cataract, diabetes medication was not. Treatment with metformin was associated with a lower risk of OAG, and other diabetes medication was associated with a lower risk of AMD. Proof of benefit would require interventional clinical trials.
No takes yet. Share an insight, caveat, or question.
Vergroesen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: